search - Mayo Clinic Laboratories

Web:	mayocliniclabs.com
Email:	mcl@mayo.edu
Telephone:	800-533-1710
International:	+1 855-379-3115
Values are valid only on day of printing

PINTP - Overview: Peripheral Smear Interpretation, Whole Blood

Interpretation of a Wright-stained peripheral blood smear

ADICI - Overview: Disseminated Intravascular Coagulation/Intravascular Coagulation and Fibrinolysis (DIC/ICF) Profile Interpretation

Interpretation of testing performed as part of a profile to evaluate laboratory evidence of disseminated intravascular coagulation

FCPEU - Overview: C-Peptide, 24-Hour Urine

Urine C-peptide is measured when a continuous assessment of B-cell function is desired or frequent blood sampling is not practical (eg, in children). C-peptide excretion in urine has been used to access pancreatic function in gestational...

5INHT - Overview: Factor V Inhibitor Profile, Technical Interpretation

Technical interpretation of inhibitor to factor V testing

5AINH - Overview: Factor V Inhibitor Profile, Professional Interpretation

Interpretation of testing for factor V inhibitors

10INT - Overview: Factor X Inhibitor Profile, Technical Interpretation

Technical interpretation of inhibitor to coagulation factor X testing

8AINH - Overview: Factor VIII Inhibitor Profile, Professional Interpretation

Interpretation for the detection of the presence and titer of a specific factor inhibitor directed against coagulation factor VIII

FGAGM - Overview: Ganglioside (Asialo-GM1, GM1, GM2, GD1a, GD1b, and GQ1b) Antibodies

Ganglioside (Asialo-GM1, GM1, GM2, GD1a, GD1b, and GQ1b) Antibodies

FETCE - Overview: Mitochondrial Respiratory Chain Enzyme Analysis (ETC) - Skin Fibroblasts

Mitochondrial Respiratory Chain Enzyme Analysis (ETC) - Skin Fibroblasts

FKEMS - Overview: Ketamine and Metabolite Screen, Plasma

Ketamine and Metabolite Screen, Plasma

FMMM - Overview: Mephedrone, MDPV and Methylone, Urine

Mephedrone, MDPV and Methylone, Urine

FFTRO - Overview: Trofile DNA Co-Receptor Tropism Assay

Detect HIV-1 coreceptor tropism; determine eligibility for CCR5 antagonist therapy such as Selzentry™ (maraviroc).

FSERO - Overview: SeroNeg RAdx3 Profile

SeroNeg RAdx3 Profile

FSULU - Overview: Thiosulfate, Urine

Thiosulfate, Urine

FFTAC - Overview: Thrombin-Antithrombin Complex

Thrombin-Antithrombin Complex

F5M - Overview: 5-Methyltetrahydrofolate

5-Methyltetrahydrofolate

FFES - Overview: Estradiol Free, Serum (includes Estradiol and SHBG)

Estradiol Free, Serum (includes Estradiol and SHBG)

FABP2 - Overview: Allergic Bronchopulmonary Aspergillosis Panel II

Allergic Bronchopulmonary Aspergillosis Panel II

FIGF1 - Overview: IGF-1, LC/MS

IGF-1, LC/MS

FIAAB - Overview: IA2 Autoantibodies

IA2 Autoantibodies

FIERA - Overview: IgE Receptor Antibody

The test detects functional autoantibodies to the Fc-epsilon receptor (high affinity IgE receptor) or to IgE and is useful in the evaluation of chronic urticaria.

CH8BI - Overview: Chromogenic Factor VIII Inhibitor Bethesda Profile Interpretation

Interpretation of CHF8P / Chromogenic Factor VIII Inhibitor Bethesda Profile, Plasma Detecting the presence and titer of a specific factor inhibitor directed against coagulation factor VIII This test is not useful for detecting the...

FHEP2 - Overview: Heparin Cofactor II

Assessment of thrombotic risk associated with heparin cofactor II levels.

UHSD2 - Overview: Hemosiderin, Random, Urine

Detecting hemosiderinuria, secondary to excess hemolysis, as in incompatible blood transfusions, severe acute hemolytic anemia, or hemochromatosis for external patients.

FNEOS - Overview: Neopterin

Increased levels of neopterin are found during impaired renal function and viral infection in transplant patients. Elevated levels are also indicators for conditions related to impaired cellular immunity.

MITAN - Overview: Mitotane, Plasma

Assessing compliance or making dosage adjustments for mitotane

FOPIA - Overview: Opiates, Serum or Plasma, Quantitative

Opiates, Serum or Plasma, Quantitative

PGN - Overview: Pregabalin, Serum

Monitoring serum pregabalin (Lyrica) concentrations, assessing compliance, and adjusting dosage in patients

ROMA2 - Overview: Risk Score, if Postmenopausal, Serum

Calculating risk assessment for finding an ovarian malignancy during surgery in postmenopausal women who present with an adnexal mass

EEEVI - Overview: Red Blood Cell (RBC) Enzyme Interpretation

Interpretation of results for the red blood cell enzyme evaluation Identifying defects of red cell enzyme metabolism Evaluating patients with Coombs-negative hemolytic anemia

ROMA1 - Overview: Risk Score, if Premenopausal, Serum

Calculating risk assessment for finding an ovarian malignancy during surgery in premenopausal women who present with an adnexal mass

FCSC - Overview: Synthetic Cannabinoid Metabolites Screen, Expanded, Urine

Synthetic Cannabinoid Metabolites Screen, Expanded, Urine

FD10S - Overview: Drugs of Abuse Screen, Serum

Drugs of Abuse Screen, Serum

FCZAC - Overview: Certolizumab and Anti-Certolizumab Antibody, DoseASSURE CTZ

Provides certolizumab drug concentration and anti-certolizumab antibodies in order to optimize treatment and facilitate clinical decision-making. This assay may be helpful in any patient on certolizumab therapy for Crohn's disease,...

2INHT - Overview: Factor II Inhibitor Profile, Technical Interpretation

Technical interpretation of inhibitor to factor II testing This test is not useful for the detection of a lupus-like circulating anticoagulant inhibitor, a nonspecific circulating anticoagulant, or other inhibitors that are not specific...

9INHT - Overview: Factor IX Inhibitor Profile Technical Interpretation

Technical interpretation of inhibitor to factor IX testing for patients with hemophilia B

7INHT - Overview: Factor VII Inhibitor Profile, Technical Interpretation

Technical interpretation of inhibitor to coagulation factor VII testing

11INT - Overview: Factor XI Inhibitor Profile, Technical Interpretation

Technical interpretation of inhibitor to coagulation factor XI testing This test is not useful for the detection of a lupus-like circulating anticoagulant inhibitor, a nonspecific circulating anticoagulant, or other inhibitors that are...